2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,958 | 90,226 | 95,991 | 193,629 | 71,032 |
| Marketable Securities | 142,031 | 160,393 | 186,846 | 146,301 | 195,238 |
| Receivables | 13,411 | 19,515 | 44,099 | 41,252 | 20,960 |
| TOTAL | $237,765 | $277,254 | $333,665 | $389,817 | $300,882 |
| Non-Current Assets | |||||
| PPE Net | 58,150 | 60,681 | 61,023 | 59,153 | 55,735 |
| Investments And Advances | 4,816 | 33,659 | 23,709 | 1,432 | 1,414 |
| Intangibles | 6,594 | 6,771 | 19,004 | 19,181 | 19,358 |
| Other Non-Current Assets | 258,101 | 262,441 | 268,312 | 272,854 | 279,276 |
| TOTAL | $327,661 | $363,552 | $372,048 | $352,620 | $355,783 |
| Total Assets | $565,426 | $640,806 | $705,713 | $742,437 | $656,665 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,028 | 5,307 | 6,274 | 13,399 | 7,208 |
| Accrued Expenses | 25,688 | 37,408 | 36,107 | 43,568 | 54,678 |
| Other current liabilities | N/A | N/A | N/A | N/A | 3,744 |
| TOTAL | $59,779 | $68,008 | $66,895 | $76,929 | $79,794 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,403 | 13,026 | 12,642 | 8,480 | 3,000 |
| Other Non-Current Liabilities | 246,429 | 250,299 | 254,110 | 257,873 | 261,405 |
| TOTAL | $250,347 | $266,376 | $271,323 | $264,184 | $266,405 |
| Total Liabilities | $310,126 | $334,384 | $338,218 | $341,113 | $346,199 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,311 | 50,625 | 50,465 | 50,199 | 50,190 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -511,217 | -454,395 | -382,757 | -340,668 | -293,647 |
| Other shareholders' equity | -204 | -916 | -1,430 | -1,950 | -2,877 |
| TOTAL | $255,300 | $306,422 | $367,495 | $401,324 | $310,466 |
| Total Liabilities And Equity | $565,426 | $640,806 | $705,713 | $742,437 | $656,665 |